Cardiac MRI in heart failure with preserved ejection fraction.
Diastolic
HFpEF
Heart failure
Left ventricular function
Magnetic resonance imaging
Journal
La Radiologia medica
ISSN: 1826-6983
Titre abrégé: Radiol Med
Pays: Italy
ID NLM: 0177625
Informations de publication
Date de publication:
19 Aug 2024
19 Aug 2024
Historique:
received:
27
11
2023
accepted:
09
08
2024
medline:
19
8
2024
pubmed:
19
8
2024
entrez:
19
8
2024
Statut:
aheadofprint
Résumé
Patients who have heart failure with preserved ejection fraction (HFpEF) have signs and symptoms of heart failure, yet their ejection fraction remains greater than or equal to 50 percent. Understanding the underlying cause of HFpEF is crucial for accurate diagnosis and effective treatment. This condition can be caused by multiple factors, including ischemic or nonischemic myocardial diseases. HFpEF is often associated with diastolic dysfunction. Cardiac magnetic resonance (CMR) allows for a precise examination of the functional and structural alterations associated with HFpEF through the measurement of volumes and mass, the assessment of systolic and diastolic function, and the analysis of tissue characteristics. We will discuss CMR imaging indicators that are specific to patients with HFpEF and their relation to the disease. These markers can be acquired through both established and emerging methods.
Identifiants
pubmed: 39158816
doi: 10.1007/s11547-024-01874-z
pii: 10.1007/s11547-024-01874-z
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Italian Society of Medical Radiology.
Références
Ma C, Luo H, Fan L, Liu X, Gao C (2020) Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis. Braz J Med Biol Res 53(7):e9646. https://doi.org/10.1590/1414-431X20209646
doi: 10.1590/1414-431X20209646
pubmed: 32520204
pmcid: 7296715
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Group ESCSD (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200. https://doi.org/10.1093/eurheartj/ehw128
doi: 10.1093/eurheartj/ehw128
pubmed: 27206819
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, Group ESCSD (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726. https://doi.org/10.1093/eurheartj/ehab368
doi: 10.1093/eurheartj/ehab368
pubmed: 34447992
Vega-Adauy J, Tok OO, Celik A, Barutcu A, Vannan (2021) Comprehensive Assessment of Heart Failure with Preserved Ejection Fraction Using Cardiac MRI. Heart Fail Clin. https://doi.org/10.1016/j.hfc.2021.03.006
doi: 10.1016/j.hfc.2021.03.006
pubmed: 34051976
Dunlay SM, Roger VL, Redfield MM (2017) Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 14(10):591–602. https://doi.org/10.1038/nrcardio.2017.65
doi: 10.1038/nrcardio.2017.65
pubmed: 28492288
Pieske B, Tschope C, de Boer RA, Fraser AG, Anker SD, Donal E, Edelmann F, Fu M, Guazzi M, Lam CSP, Lancellotti P, Melenovsky V, Morris DA, Nagel E, Pieske-Kraigher E, Ponikowski P, Solomon SD, Vasan RS, Rutten FH, Voors AA, Ruschitzka F, Paulus WJ, Seferovic P, Filippatos G (2020) How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 22(3):391–412. https://doi.org/10.1002/ejhf.1741
doi: 10.1002/ejhf.1741
pubmed: 32133741
Kanagala P, Cheng ASH, Singh A, McAdam J, Marsh AM, Arnold JR, Squire IB, Ng LL, McCann GP (2018) Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction - implications for clinical trials. J Cardiovasc Magn Reson 20(1):4. https://doi.org/10.1186/s12968-017-0424-9
doi: 10.1186/s12968-017-0424-9
pubmed: 29321034
pmcid: 5763769
Xanthopoulos A, Triposkiadis F, Starling RC (2018) Heart failure with preserved ejection fraction: classification based upon phenotype is essential for diagnosis and treatment. Trends Cardiovasc Med 28(6):392–400. https://doi.org/10.1016/j.tcm.2018.01.001
doi: 10.1016/j.tcm.2018.01.001
pubmed: 29471985
Chamsi-Pasha MA, Zhan Y, Debs D, Shah (2020) CMR in the Evaluation of Diastolic Dysfunction and Phenotyping of HFpEF: current role and future perspectives. JACC Cardiovasc Imag. https://doi.org/10.1016/j.jcmg.2019.02.031
doi: 10.1016/j.jcmg.2019.02.031
Zawadzka MM, Grabowski M, Kaplon-Cieslicka A (2022) Phenotyping in heart failure with preserved ejection fraction: a key to find effective treatment. Adv Clin Exp Med. https://doi.org/10.17219/acem/149728
doi: 10.17219/acem/149728
pubmed: 35581935
Webb J, Fovargue L, Tondel K, Porter B, Sieniewicz B, Gould J, Rinaldi CA, Ismail T, Chiribiri A, Carr-White G (2018) The emerging role of cardiac magnetic resonance imaging in the evaluation of patients with HFpEF. Curr Heart Fail Rep 15(1):1–9. https://doi.org/10.1007/s11897-018-0372-1
doi: 10.1007/s11897-018-0372-1
pubmed: 29404975
pmcid: 5811579
Borlaug BA (2014) The pathophysiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 11(9):507–515. https://doi.org/10.1038/nrcardio.2014.83
doi: 10.1038/nrcardio.2014.83
pubmed: 24958077
Bojer AS, Soerensen MH, Gaede P, Myerson S, Madsen PL (2021) Left ventricular diastolic function studied with magnetic resonance imaging: a systematic review of techniques and relation to established measures of diastolic function. Diagnostics (Basel). https://doi.org/10.3390/diagnostics11071282
doi: 10.3390/diagnostics11071282
pubmed: 34359363
Bernard PP, Albert JJB, Johan MB, Rob J, Dominique D, Paul MP, Christiaan JV, Hildo JL (2005) Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement. J Am Coll Cardiol 45(7):1109–1116. https://doi.org/10.1016/j.jacc.2004.12.051
doi: 10.1016/j.jacc.2004.12.051
Caudron J, Fares J, Bauer F, Dacher JN (2011) Evaluation of left ventricular diastolic function with cardiac MR imaging. Radiographics 31(1):239–259. https://doi.org/10.1148/rg.311105049
doi: 10.1148/rg.311105049
pubmed: 21257944
Westenberg JJ (2011) CMR for assessment of diastolic function. Curr Cardiovasc Imaging Rep 4(2):149–158. https://doi.org/10.1007/s12410-011-9070-z
doi: 10.1007/s12410-011-9070-z
pubmed: 21475412
pmcid: 3047728
Paelinck BP, de Roos A, Bax JJ, Bosmans JM, van Der Geest RJ, Dhondt D, Parizel PM, Vrints CJ, Lamb HJ (2005) Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement. J Am Coll Cardiol 45(7):1109–1116. https://doi.org/10.1016/j.jacc.2004.12.051
doi: 10.1016/j.jacc.2004.12.051
pubmed: 15808772
Rathi VK, Doyle M, Yamrozik J, Williams RB, Caruppannan K, Truman C, Vido D, Biederman RW (2008) Routine evaluation of left ventricular diastolic function by cardiovascular magnetic resonance: a practical approach. J Cardiovasc Magn Reson 10:36. https://doi.org/10.1186/1532-429X-10-36
doi: 10.1186/1532-429X-10-36
pubmed: 18611254
pmcid: 2481245
Buss SJ, Krautz B, Schnackenburg B, Abdel-Aty H, Santos MF, Andre F, Maertens MJ, Mereles D, Korosoglou G, Giannitsis E, Katus HA, Steen H (2014) Classification of diastolic function with phase-contrast cardiac magnetic resonance imaging: validation with echocardiography and age-related reference values. Clin Res Cardiol 103(6):441–450. https://doi.org/10.1007/s00392-014-0669-3
doi: 10.1007/s00392-014-0669-3
pubmed: 24452509
Shehata ML, Cheng S, Osman NF, Bluemke DA, Lima JA (2009) Myocardial tissue tagging with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 11:55. https://doi.org/10.1186/1532-429X-11-55
doi: 10.1186/1532-429X-11-55
pubmed: 20025732
pmcid: 2809051
Cao JJ, Ngai N, Duncanson L, Cheng J, Gliganic K, Chen Q (2018) A comparison of both DENSE and feature tracking techniques with tagging for the cardiovascular magnetic resonance assessment of myocardial strain. J Cardiovasc Magnet Reson. https://doi.org/10.1186/s12968-018-0448-9
doi: 10.1186/s12968-018-0448-9
Simpson RM, Keegan J, Firmin DN (2013) MR assessment of regional myocardial mechanics. J Magn Reson Imaging 37(3):576–599. https://doi.org/10.1002/jmri.23756
doi: 10.1002/jmri.23756
pubmed: 22826177
Ibrahim E-SH (2011) Myocardial tagging by Cardiovascular Magnetic Resonance: evolution of techniques–pulse sequences, analysis algorithms, and applications. J Cardiovasc Magn Reson 13(1):36. https://doi.org/10.1186/1532-429x-13-36
doi: 10.1186/1532-429x-13-36
pubmed: 21798021
pmcid: 3166900
Kawel-Boehm N, Hetzel SJ, Ambale-Venkatesh B, Captur G, Francois CJ, Jerosch-Herold M, Salerno M, Teague SD, Valsangiacomo-Buechel E, van der Geest RJ, Bluemke DA (2020) Reference ranges (“normal values”) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update. J Cardiovasc Magn Reson 22(1):87. https://doi.org/10.1186/s12968-020-00683-3
doi: 10.1186/s12968-020-00683-3
pubmed: 33308262
pmcid: 7734766
Onishi T, Saha SK, Delgado-Montero A, Ludwig DR, Onishi T, Schelbert EB, Schwartzman D, Gorcsan J 3rd (2015) Global longitudinal strain and global circumferential strain by speckle-tracking echocardiography and feature-tracking cardiac magnetic resonance imaging: comparison with left ventricular ejection fraction. J Am Soc Echocardiogr 28(5):587–596. https://doi.org/10.1016/j.echo.2014.11.018
doi: 10.1016/j.echo.2014.11.018
pubmed: 25577185
Ito H, Ishida M, Makino W, Goto Y, Ichikawa Y, Kitagawa K, Omori T, Dohi K, Ito M, Sakuma H (2020) Cardiovascular magnetic resonance feature tracking for characterization of patients with heart failure with preserved ejection fraction: correlation of global longitudinal strain with invasive diastolic functional indices. J Cardiovasc Magn Reson 22(1):42. https://doi.org/10.1186/s12968-020-00636-w
doi: 10.1186/s12968-020-00636-w
pubmed: 32498688
pmcid: 7271439
Kammerlander AA, Kraiger JA, Nitsche C, Dona C, Duca F, Zotter-Tufaro C, Binder C, Aschauer S, Loewe C, Hengstenberg C, Bonderman D, Mascherbauer J (2019) Global longitudinal strain by CMR feature tracking is associated with outcome in HFPEF. JACC Cardiovasc Imaging 12(8 Pt 1):1585–1587. https://doi.org/10.1016/j.jcmg.2019.02.016
doi: 10.1016/j.jcmg.2019.02.016
pubmed: 31005535
Tadic M, Pieske-Kraigher E, Cuspidi C, Genger M, Morris DA, Zhang K, Walther NA, Pieske B (2017) Left ventricular strain and twisting in heart failure with preserved ejection fraction: an updated review. Heart Fail Rev 22(3):371–379. https://doi.org/10.1007/s10741-017-9618-3
doi: 10.1007/s10741-017-9618-3
pubmed: 28405789
Sharifov OF, Schiros CG, Aban I, Perry GJ, Dell’italia LJ, Lloyd SG, Denney TS Jr, Gupta H (2017) Left ventricular torsion shear angle volume approach for noninvasive evaluation of diastolic dysfunction in preserved ejection fraction. J Am Heart Assoc. https://doi.org/10.1161/JAHA.117.007039
doi: 10.1161/JAHA.117.007039
pubmed: 29288156
pmcid: 5778962
Barison A, Aimo A, Todiere G, Grigoratos C, Aquaro GD, Emdin M (2022) Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction. Heart Fail Rev 27(1):191–205. https://doi.org/10.1007/s10741-020-09998-w
doi: 10.1007/s10741-020-09998-w
pubmed: 32572736
Maceira AM, Cosín-Sales J, Roughton M, Prasad SK, Pennell DJ (2010) Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 12(1):65. https://doi.org/10.1186/1532-429x-12-65
doi: 10.1186/1532-429x-12-65
pubmed: 21070636
pmcid: 2994941
Takemoto Y, Barnes ME, Seward JB, Lester SJ, Appleton CA, Gersh BJ, Bailey KR, Tsang TS (2005) Usefulness of left atrial volume in predicting first congestive heart failure in patients > or = 65 years of age with well-preserved left ventricular systolic function. Am J Cardiol 96(6):832–836. https://doi.org/10.1016/j.amjcard.2005.05.031
doi: 10.1016/j.amjcard.2005.05.031
pubmed: 16169372
Habibi M, Chahal H, Opdahl A, Gjesdal O, Helle-Valle TM, Heckbert SR, McClelland R, Wu C, Shea S, Hundley G, Bluemke DA, Lima JA (2014) Association of CMR-measured LA function with heart failure development: results from the MESA study. JACC Cardiovasc Imaging 7(6):570–579. https://doi.org/10.1016/j.jcmg.2014.01.016
doi: 10.1016/j.jcmg.2014.01.016
pubmed: 24813967
pmcid: 4129378
Patel DA, Lavie CJ, Gilliland YE, Shah SB, Dinshaw HK, Milani RV (2015) Prediction of All-cause mortality by the left atrial volume index in patients with normal left ventricular filling pressure and preserved ejection fraction. Mayo Clin Proc 90(11):1499–1505. https://doi.org/10.1016/j.mayocp.2015.07.021
doi: 10.1016/j.mayocp.2015.07.021
pubmed: 26455887
Melenovsky V, Hwang SJ, Redfield MM, Zakeri R, Lin G, Borlaug BA (2015) Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction. Circ Heart Fail 8(2):295–303. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001667
doi: 10.1161/CIRCHEARTFAILURE.114.001667
pubmed: 25593126
Gupta S, Matulevicius SA, Ayers CR, Berry JD, Patel PC, Markham DW, Levine BD, Chin KM, de Lemos JA, Peshock RM, Drazner MH (2013) Left atrial structure and function and clinical outcomes in the general population. Eur Heart J 34(4):278–285. https://doi.org/10.1093/eurheartj/ehs188
doi: 10.1093/eurheartj/ehs188
pubmed: 22782941
Fang F, Lee AP, Yu CM (2014) Left atrial function in heart failure with impaired and preserved ejection fraction. Curr Opin Cardiol 29(5):430–436. https://doi.org/10.1097/HCO.0000000000000091
doi: 10.1097/HCO.0000000000000091
pubmed: 25032726
Assadi H, Jones R, Swift AJ, Al-Mohammad A, Garg P (2021) Cardiac MRI for the prognostication of heart failure with preserved ejection fraction: a systematic review and meta-analysis. Magn Reson Imaging 76:116–122. https://doi.org/10.1016/j.mri.2020.11.011
doi: 10.1016/j.mri.2020.11.011
pubmed: 33221422
pmcid: 7819363
van Woerden G, van Veldhuisen DJ, Gorter TM, Willems TP, van Empel VPM, Peters A, Pundziute G, Op den Akker JW, Rienstra M, Westenbrink BD (2022) The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction. Heart Vessels 37(2):273–281. https://doi.org/10.1007/s00380-021-01910-2
doi: 10.1007/s00380-021-01910-2
pubmed: 34292389
Kato S, Saito N, Kirigaya H, Gyotoku D, Iinuma N, Kusakawa Y, Iguchi K, Nakachi T, Fukui K, Futaki M, Iwasawa T, Taguri M, Kimura K, Umemura S (2015) Prognostic significance of quantitative assessment of focal myocardial fibrosis in patients with heart failure with preserved ejection fraction. Int J Cardiol 191:314–319. https://doi.org/10.1016/j.ijcard.2015.05.048
doi: 10.1016/j.ijcard.2015.05.048
pubmed: 26005800
Murtagh G, Laffin LJ, Beshai JF, Maffessanti F, Bonham CA, Patel AV, Yu Z, Addetia K, Mor-Avi V, Moss JD, Hogarth DK, Sweiss NJ, Lang RM, Patel AR (2016) Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance. Circ Cardiovasc Imag 9(1):e003738. https://doi.org/10.1161/CIRCIMAGING.115.003738
doi: 10.1161/CIRCIMAGING.115.003738
Child N, Suna G, Dabir D, Yap ML, Rogers T, Kathirgamanathan M, Arroyo-Ucar E, Hinojar R, Mahmoud I, Young C, Wendler O, Mayr M, Sandhu B, Morton G, Muhly-Reinholz M, Dimmeler S, Nagel E, Puntmann VO (2018) Comparison of MOLLI, shMOLLLI, and SASHA in discrimination between health and disease and relationship with histologically derived collagen volume fraction. Eur Heart J Cardiovasc Imag 19(7):768–776. https://doi.org/10.1093/ehjci/jex309
doi: 10.1093/ehjci/jex309
Kanagala P, Cheng ASH, Singh A, Khan JN, Gulsin GS, Patel P, Gupta P, Arnold JR, Squire IB, Ng LL, McCann GP (2019) Relationship between focal and diffuse fibrosis assessed by CMR and clinical outcomes in heart failure with preserved ejection fraction. JACC Cardiovasc Imaging 12(11 Pt 2):2291–2301. https://doi.org/10.1016/j.jcmg.2018.11.031
doi: 10.1016/j.jcmg.2018.11.031
pubmed: 30772227
Garg P, Assadi H, Jones R, Chan WB, Metherall P, Thomas R, van der Geest R, Swift AJ, Al-Mohammad A (2021) Left ventricular fibrosis and hypertrophy are associated with mortality in heart failure with preserved ejection fraction. Sci Rep 11(1):617. https://doi.org/10.1038/s41598-020-79729-6
doi: 10.1038/s41598-020-79729-6
pubmed: 33436786
pmcid: 7804435
Pezel T, Viallon M, Croisille P, Sebbag L, Bochaton T, Garot J, Lima JAC, Mewton N (2021) Imaging interstitial fibrosis, left ventricular remodeling, and function in stage A and B heart failure. JACC Cardiovasc Imaging 14(5):1038–1052. https://doi.org/10.1016/j.jcmg.2020.05.036
doi: 10.1016/j.jcmg.2020.05.036
pubmed: 32828781
Su MY, Lin LY, Tseng YH, Chang CC, Wu CK, Lin JL, Tseng WY (2014) CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF. JACC Cardiovasc Imaging 7(10):991–997. https://doi.org/10.1016/j.jcmg.2014.04.022
doi: 10.1016/j.jcmg.2014.04.022
pubmed: 25240451
Schelbert EB, Fridman Y, Wong TC, Abu Daya H, Piehler KM, Kadakkal A, Miller CA, Ugander M, Maanja M, Kellman P, Shah DJ, Abebe KZ, Simon MA, Quarta G, Senni M, Butler J, Diez J, Redfield MM, Gheorghiade M (2017) Temporal relation between myocardial fibrosis and heart failure with preserved ejection fraction: association with baseline disease severity and subsequent outcome. JAMA Cardiol 2(9):995–1006. https://doi.org/10.1001/jamacardio.2017.2511
doi: 10.1001/jamacardio.2017.2511
pubmed: 28768311
pmcid: 5710176
Rommel KP, von Roeder M, Latuscynski K, Oberueck C, Blazek S, Fengler K, Besler C, Sandri M, Lucke C, Gutberlet M, Linke A, Schuler G, Lurz P (2016) Extracellular volume fraction for characterization of patients with heart failure and preserved ejection fraction. J Am Coll Cardiol 67(15):1815–1825. https://doi.org/10.1016/j.jacc.2016.02.018
doi: 10.1016/j.jacc.2016.02.018
pubmed: 27081022
Mascherbauer J, Marzluf BA, Tufaro C, Pfaffenberger S, Graf A, Wexberg P, Panzenbock A, Jakowitsch J, Bangert C, Laimer D, Schreiber C, Karakus G, Hulsmann M, Pacher R, Lang IM, Maurer G, Bonderman D (2013) Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging 6(6):1056–1065. https://doi.org/10.1161/CIRCIMAGING.113.000633
doi: 10.1161/CIRCIMAGING.113.000633
pubmed: 24036385
Golukhova E, Bulaeva N, Alexandrova S, Gromova O, Berdibekov B (2022) Prognostic value of characterizing myocardial tissue by cardiac MRI with T1 mapping in HFpEF patients: a systematic review and meta-analysis. J Clin Med. https://doi.org/10.3390/jcm11092531
doi: 10.3390/jcm11092531
pubmed: 35566654
pmcid: 9101149
van Veldhuisen DJ, de Boer RA (2016) Ischaemia in heart failure with preserved ejection fraction; is it important? Eur J Heart Fail 18(5):577–578. https://doi.org/10.1002/ejhf.526
doi: 10.1002/ejhf.526
pubmed: 27095562
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, Group ESCSD (2022) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 24(1):4–131. https://doi.org/10.1002/ejhf.2333
doi: 10.1002/ejhf.2333
pubmed: 35083827
Marano R, Natale L, Chiribiri A, Pirro F, Silvestri V, Coppola G, Bonomo L (2015) Cardiac MR perfusion imaging: where we are. Radiol Med 120(2):190–205. https://doi.org/10.1007/s11547-014-0435-7
doi: 10.1007/s11547-014-0435-7
pubmed: 25030969
Pezel T, Garot J (2022) A new role for stress cardiac magnetic resonance imaging in patients with heart failure and preserved ejection fraction. Arch Cardiovasc Dis 115(1):1–3. https://doi.org/10.1016/j.acvd.2021.11.004
doi: 10.1016/j.acvd.2021.11.004
pubmed: 34972638
Elgendy IY, Pepine CJ (2019) Heart failure with preserved ejection fraction: is ischemia due to coronary microvascular dysfunction a mechanistic factor? Am J Med 132(6):692–697. https://doi.org/10.1016/j.amjmed.2018.12.038
doi: 10.1016/j.amjmed.2018.12.038
pubmed: 30684452
pmcid: 7722793
Tona F, Montisci R, Iop L, Civieri G (2021) Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction. Rev Cardiovasc Med 22(1):97–104. https://doi.org/10.31083/j.rcm.2021.01.277
doi: 10.31083/j.rcm.2021.01.277
pubmed: 33792251
Arnold JR, Kanagala P, Budgeon CA, Jerosch-Herold M, Gulsin GS, Singh A, Khan JN, Chan DCS, Squire IB, Ng LL, McCann GP (2022) Prevalence and prognostic significance of microvascular dysfunction in heart failure with preserved ejection fraction. JACC Cardiovasc Imaging. https://doi.org/10.1016/j.jcmg.2021.11.022
doi: 10.1016/j.jcmg.2021.11.022
pubmed: 35033490
Filice M, Golino M, Denora M, Ruscio E, Ingrasciotta G, Lamendola P, Manfredonia L, Villano A, Bisignani A, Ravenna SE, A DEV, Lanza O, Crea F, Lanza GA, (2022) Coronary microvascular dysfunction and findings of heart failure with preserved ejection fraction in patients with microvascular angina. Minerva Med. https://doi.org/10.23736/S0026-4806.21.07135-4
doi: 10.23736/S0026-4806.21.07135-4
pubmed: 35166097
Belyavskiy E, Morris DA, Url-Michitsch M, Verheyen N, Meinitzer A, Radhakrishnan AK, Kropf M, Frydas A, Ovchinnikov AG, Schmidt A, Tadic M, Genger M, Lindhorst R, Bobenko A, Tschöpe C, Edelmann F, Pieske-Kraigher E, Pieske B (2019) Diastolic stress test echocardiography in patients with suspected heart failure with preserved ejection fraction: a pilot study. (2055–5822 (Electronic))
Reiter U, Reiter G, Manninger M, Adelsmayr G, Schipke J, Alogna A, Rajces A, Stalder AF, Greiser A, Mühlfeld C, Scherr D, Post H, Pieske B, Fuchsjäger M (2016) Early-stage heart failure with preserved ejection fraction in the pig: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 18(1):63. https://doi.org/10.1186/s12968-016-0283-9
doi: 10.1186/s12968-016-0283-9
pubmed: 27688028
pmcid: 5043627
Gorter TM, Hoendermis ES, van Veldhuisen DJ, Voors AA, Lam CS, Geelhoed B, Willems TP, van Melle JP (2016) Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Eur J Heart Fail 18(12):1472–1487. https://doi.org/10.1002/ejhf.630
doi: 10.1002/ejhf.630
pubmed: 27650220
Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA (2014) Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 35(48):3452–3462. https://doi.org/10.1093/eurheartj/ehu193
doi: 10.1093/eurheartj/ehu193
pubmed: 24875795
pmcid: 4425842
Aschauer S, Kammerlander AA, Zotter-Tufaro C, Ristl R, Pfaffenberger S, Bachmann A, Duca F, Marzluf BA, Bonderman D, Mascherbauer J (2016) The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics. Eur J Heart Fail 18(1):71–80. https://doi.org/10.1002/ejhf.418
doi: 10.1002/ejhf.418
pubmed: 26449727
Mostafa S (2019) Assessment of right ventricular systolic function in heart failure with preserved, reduced and mid-range ejection fraction. Indian Heart J 71(5):406–411. https://doi.org/10.1016/j.ihj.2019.11.252
doi: 10.1016/j.ihj.2019.11.252
pubmed: 32035524
pmcid: 7013188
Berglund F, Pina P, Herrera CJ (2020) Right ventricle in heart failure with preserved ejection fraction. Heart 106(23):1798–1804. https://doi.org/10.1136/heartjnl-2020-317342
doi: 10.1136/heartjnl-2020-317342
pubmed: 32895314
Gorter TM, van Veldhuisen DJ, Bauersachs J, Borlaug BA, Celutkiene J, Coats AJS, Crespo-Leiro MG, Guazzi M, Harjola VP, Heymans S, Hill L, Lainscak M, Lam CSP, Lund LH, Lyon AR, Mebazaa A, Mueller C, Paulus WJ, Pieske B, Piepoli MF, Ruschitzka F, Rutten FH, Seferovic PM, Solomon SD, Shah SJ, Triposkiadis F, Wachter R, Tschope C, de Boer RA (2018) Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 20(1):16–37. https://doi.org/10.1002/ejhf.1029
doi: 10.1002/ejhf.1029
pubmed: 29044932
Garcia MJ (2016) Constrictive pericarditis versus restrictive cardiomyopathy? J Am Coll Cardiol 67(17):2061–2076. https://doi.org/10.1016/j.jacc.2016.01.076
doi: 10.1016/j.jacc.2016.01.076
pubmed: 27126534
Oh JK, Chang SA, Choe YH, Young PM (2012) CMR imaging for diastolic hemodynamic assessment fantasy or reality? JACC Cardiovasc Imaging 5(1):25–27. https://doi.org/10.1016/j.jcmg.2011.08.018
doi: 10.1016/j.jcmg.2011.08.018
pubmed: 22239889
Aldweib N, Farah V, Biederman RWW (2018) Clinical utility of cardiac magnetic resonance imaging in pericardial diseases. Curr Cardiol Rev 14(3):200–212. https://doi.org/10.2174/1573403X14666180619104515
doi: 10.2174/1573403X14666180619104515
pubmed: 29921208
pmcid: 6131401
Ashkir Z, Myerson S, Neubauer S, Carlhall CJ, Ebbers T, Raman B (2022) Four-dimensional flow cardiac magnetic resonance assessment of left ventricular diastolic function. Front Cardiovasc Med 9:866131. https://doi.org/10.3389/fcvm.2022.866131
doi: 10.3389/fcvm.2022.866131
pubmed: 35935619
pmcid: 9355735
Svalbring E, Fredriksson A, Eriksson J, Dyverfeldt P, Ebbers T, Bolger AF, Engvall J, Carlhäll C-J (2016) Altered diastolic flow patterns and kinetic energy in subtle left ventricular remodeling and dysfunction detected by 4D flow MRI. PLoS ONE 11(8):e0161391
doi: 10.1371/journal.pone.0161391
pubmed: 27532640
pmcid: 4988651
Crandon S, Westenberg JJM, Swoboda PP, Fent GJ, Foley JRJ, Chew PG, Brown LAE, Saunderson C, Al-Mohammad A, Greenwood JP, van der Geest RJ, Dall’Armellina E, Plein S, Garg P (2018) Impact of Age and Diastolic Function on Novel, 4D flow CMR Biomarkers of Left Ventricular Blood Flow Kinetic Energy. Sci Rep 8(1):14436. https://doi.org/10.1038/s41598-018-32707-5
doi: 10.1038/s41598-018-32707-5
pubmed: 30258186
pmcid: 6158175
Garg P, Crandon S, Swoboda PP, Fent GJ, Foley JRJ, Chew PG, Brown LAE, Vijayan S, Hassell M, Nijveldt R, Bissell M, Elbaz MSM, Al-Mohammad A, Westenberg JJM, Greenwood JP, van der Geest RJ, Plein S, Dall’Armellina E (2018) Left ventricular blood flow kinetic energy after myocardial infarction - insights from 4D flow cardiovascular magnetic resonance. J Cardiovasc Magn Reson 20(1):61. https://doi.org/10.1186/s12968-018-0483-6
doi: 10.1186/s12968-018-0483-6
pubmed: 30165869
pmcid: 6117925
Riva A, Sturla F, Pica S, Camporeale A, Tondi L, Saitta S, Caimi A, Giese D, Palladini G, Milani P, Castelvecchio S, Menicanti L, Redaelli A, Lombardi M, Votta E (2022) Comparison of Four-Dimensional Magnetic Resonance Imaging Analysis of Left Ventricular Fluid Dynamics and Energetics in Ischemic and Restrictive Cardiomyopathies. J Magn Reson Imaging 56(4):1157–1170. https://doi.org/10.1002/jmri.28076
doi: 10.1002/jmri.28076
pubmed: 35075711
pmcid: 9541919
Arvidsson PM, Nelsson A, Magnusson M, Smith JG, Carlsson M, Arheden H (2022) Hemodynamic force analysis is not ready for clinical trials on HFpEF. Sci Rep 12(1):4017
doi: 10.1038/s41598-022-08023-4
pubmed: 35256713
pmcid: 8901629
Schäfer M, Humphries S, Stenmark KR, Kheyfets VO, Buckner JK, Hunter KS, Fenster BE (2018) 4D-flow cardiac magnetic resonance-derived vorticity is sensitive marker of left ventricular diastolic dysfunction in patients with mild-to-moderate chronic obstructive pulmonary disease. Eur Heart J-Cardiovasc Imaging 19(4):415–424
doi: 10.1093/ehjci/jex069
pubmed: 28460004
He J, Yang W, Jiang Y, Sun X, Zhao S, Weiss R, Sirajuddin A, Lu M (2021) Heart failure with preserved ejection fraction assessed by cardiac magnetic resonance: From clinical uses to emerging techniques. Trends Cardiovasc Med. https://doi.org/10.1016/j.tcm.2021.12.006
doi: 10.1016/j.tcm.2021.12.006
pubmed: 34933114
Lau C, Elshibly MMM, Kanagala P, Khoo JP, Arnold JR, Hothi SS (2022) The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction. Front Cardiovasc Med 9:922398. https://doi.org/10.3389/fcvm.2022.922398
doi: 10.3389/fcvm.2022.922398
pubmed: 35924215
pmcid: 9339656
van der Meer P, Gaggin HK, Dec GW (2019) ACC/AHA versus ESC guidelines on heart failure: JACC guideline comparison. J Am Coll Cardiol 73(21):2756–2768. https://doi.org/10.1016/j.jacc.2019.03.478
doi: 10.1016/j.jacc.2019.03.478
pubmed: 31146820